MIRA Pharmaceuticals Inc. (NASDAQ: MIRA) announced it has amended its licensing agreement with MIRALOGX LLC to expand rights for its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE